BC Week In Review | May 8, 2006
Clinical News

DrugMEt regulatory update

Jurilab received European CE Mark approval for in vitro diagnostic use of its DrugMEt pharmacogenetic test. Nanogen Inc. (NGEN, San Diego, Calif.) has exclusive worldwide distribution rights, excluding Japan, for the microarray-based genotyping test that...
BC Extra | May 3, 2006
Company News

Jurilab pharmacogenetic test gets CE Mark

Jurilab (Kuopio, Finland ) received European CE Mark approval for in vitro diagnostic use of its DrugMEt pharmacogenetic test. Nanogen (NGEN) has exclusive worldwide distribution rights, excluding Japan, for the microarray-based genotyping test that can detect...
BC Week In Review | Sep 13, 2004
Company News

Jurilab, Summit Pharmaceuticals International deal

Summit will seek partners in Japan for Jurilab's R&D programs and technologies. These include Jurilab's collection of DNA samples from more than 20,000 people in the East Finland founder population, genetic markers, microarrays, and analytical...
BC Week In Review | Mar 29, 2004
Company News

Jurilab sales and marketing update

Jurilab launched its DrugMEt microarray-based genotyping test for variations involved in drug metabolism. Jurilab Ltd. , Kuopio, Finland   Business: Microarrays  ...
Items per page:
1 - 4 of 4